Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets

Published - Oct 2012| Analyst - George W. Jackson| Code - BIO071B
Market Research Report Single User License: $3325

Report Highlights

The global aptamer market was valued at $40 million in 2011 and should reach nearly $99 million in 2012. Total market value is expected to reach nearly $3.7 billion in 2017 with a five-year compound annual growth rate (CAGR) of 106.3%.

Report Includes

  • An overview of the specific applications for nucleic acid aptamers for therapeutic and diagnostic purposes, with a focus on applications judged to be commercially viable rather than enabling of basic research
  • Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
  • Identification of emerging technology growth opportunities in aptamer use as adjuvants for siRNA delivery, vaccines, and antisense technologies
  • Examination of high growth and market potential segments of the industry, and new and established companies in the arena
  • Comprehensive company profiles of major players in the industry.

Report Scope

The scope of this report covers all major known applications of aptamers in the biotechnology arena.  Nevertheless, the study focuses on applications judged to be commercially viable rather than enabling of basic research.

Analyst Credentials

Dr. George William (“Bill”) Jackson, Ph.D., serves as a Senior Scientist at BioTex, Inc. in Houston, Texas.  Additionally, Dr. Jackson is founder and chief scientist of Base Pair Biotechnologies, Inc., a company specializing in aptamer discovery services.  He is an active researcher in the molecular biology and diagnostics field with numerous federal grants in the area.  Particularly, he has served as principal investigator (PI) on several projects utilizing aptamers for both sensing and bioremediation.  Most recently, he serves as PI on a research grant from the National Institutes of Health to select “an aptamer to everything,” which was formally titled, “Platform for Massively Parallel Selection of Aptamer Ligands.” He has served on peer review panels at the National Institutes of Health and the Environmental Protection Agency on topics ranging from biodefense and medical diagnostics to water quality.  Dr. Jackson has authored more than 30 peer-reviewed publications or conference proceedings and is the inventor on four issued and 13 pending patents.

Co-author, Dr. Ulrich Strych, Ph.D., is a Research Assistant Professor at the University of Houston.  Dr. Strych is an experienced molecular biologist who has collaborated with Dr. Jackson for more than five years on various aptamer-related research projects.  Dr. Strych has extensive modern molecular biology experience, methods development know-how in surface plasmon resonance (SPR) and other bioanalytical approaches, and hands-on experience with other methods of high-throughput combinatorial screening, such as phage display.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at(+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter Name Pages Price
Full Report: Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets 137 $3325
Chapter- 1: INTRODUCTION 3
Chapter- 2: SUMMARY 4 $250
Chapter- 3: OVERVIEW 5 $182
Chapter- 4: MARKETS BY TECHNOLOGY TYPE 43 $1565
Chapter- 5: MARKETS BY APPLICATIONS 20 $728
Chapter- 6: INTELLECTUAL PROPERTY ANALYSIS 16 $582
Chapter- 7: INDUSTRY STRUCTURE AND COMPETITIVE ANALYSIS 9 $328
Chapter- 8: COMPANY PROFILES 15 $546
Chapter- 9: REFERENCES 22 $801
List of Tables
List of Figures
Download Table of Contents
RELATED REPORTS
Share This Report